Premier Alternatives

Qnovia

Richmond, VA · Founded 2018 · Privately Held (backing)

Developer of a drug delivery platform designed to advance pharmaceutical research and treatments aimed at saving lives. Qnovia is based in Richmond, VA and was founded in 2018. It was valued at $250 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $43.5 million across 2 recorded rounds; the latest was a $14.2 million early-stage round in Oct 2024.

PMV mark · valuation
$250.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$43.5M
Last round
Early Stage VC
Oct 2024

Qnovia key facts

as of Oct 2026
  • Developer of a drug delivery platform designed to advance pharmaceutical research and treatments aimed at saving lives.
  • Qnovia is valued at approximately $250.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $43.5M across 2 recorded rounds; the latest was Early Stage VC ($14.2M) in Oct 2024.
  • Notable investors include Gaingels, Evolution VC Partners, Sand Hill Angels, DG Ventures, DG Ventures (Tokyo) — 11 tracked in total.
  • Qnovia has filed 2 Form Ds with the SEC since 2023, most recently Nov 2024 ($14.2M sold to 7 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$250.0M

Valued at $250.0M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Qnovia with a free account
  • ·The complete investor list: 11 names
  • ·Watch Qnovia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Qnovia funding rounds

2 rounds
Oct 2024Early Stage VC$14.2MSEC filing▮
May 2023Seed Round$2.9MSEC filing▮
Full funding history →

Qnovia valuation

Qnovia was valued at $250 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Qnovia raised?

Qnovia has raised $43.5 million in total; 2 of its rounds are on record. The largest on record was a $2.9 million seed round in May 2023; the most recent was a $14.2 million early-stage round in Oct 2024.

Qnovia has filed 2 Form Ds with the SEC since 2023, most recently in Nov 2024 ($14.2 million sold to 7 investors).

Qnovia investors

11 investors are on record for Qnovia, including Gaingels, Evolution VC Partners, Sand Hill Angels and DG Ventures. The early-stage round in Oct 2024 drew 7 investors.

About Qnovia

Developer of a drug delivery platform designed to advance pharmaceutical research and treatments aimed at saving lives. The company's platform offers an inhalation-based technology that addresses many of the limitations of traditional pharmaceutical drug delivery systems to improve patient outcomes that optimize human factors and tackle critical medical challenges, enabling patients to get a variety of new inhaled therapies and improve health.

Sector
Healthcare
HQ
Richmond, VA, United States
Founded
2018
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.